Budget 2026: Volume to value - How India can get a quiet superpower

India Budget: India's pharmaceutical industry, a global leader in volume, is poised to leverage its scale for greater international influence. The upcoming Union Budget 2026-27 presents a crucial opportunity to shift focus from low-margin generics to high-value segments like biologics and novel drug discovery.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OEbw4tn
via IFTTT

Read More

HC seeks Novo Nordisk's reply on Natco plea to revoke patent

The Delhi High Court has asked Novo Nordisk to explain why its patent for the diabetes and weight loss drug semaglutide should not be cancelled. Natco Pharma filed the petition. Novo Nordisk's patent expires in March. This has sparked patent disputes as other companies aim to produce their own versions of the drug.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WFIrpbg
via IFTTT

Read More

Biocon Biologics to introduce three new biosimilars for cancer treatment

Biocon Biologics will launch three new oncology biosimilars. These include Trastuzumab/Hyaluronidase, Nivolumab, and Pembrolizumab. The company aims to expand access to vital cancer treatments. These biosimilars will offer cost-effective alternatives. Biocon Biologics will have one of the most comprehensive oncology portfolios. This move strengthens its commitment to patient care.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/f9msa6p
via IFTTT

Read More

Max Healthcare partners with The Learning Lab for advance healthcare capacity building, research

Max Healthcare has partnered with UK-based The Learning Lab to advance healthcare capacity-building and foster joint research. The collaboration will co-create training modules for healthcare professionals, aiming to strengthen clinical competencies and improve patient outcomes. This initiative combines Max Healthcare's clinical experience with The Learning Lab's educational expertise to deliver practical, evidence-based learning.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uA3vO4L
via IFTTT

Read More

IIT Roorkee hosts 'AHEAD 2025' global health conference

IIT Roorkee hosted the "AHEAD 2025" International Conference on Health and Development, bringing together global experts to address critical challenges. The event focused on policy-relevant research for health systems resilience, climate health, and demographic change, aligning with India's development agenda and SDGs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/BZXKoE6
via IFTTT

Read More

Indian fertility experts advise caution on clinical use of new 'Non-Invasive' Embryo Genetic Test

Leading Indian fertility experts have cautioned against using non-invasive embryo genetic testing (niPGT) for routine clinical decisions. A joint review by ISAR, IFS, and ACE found the technique prone to high misdiagnosis rates, potentially leading to incorrect embryo selection or discarding. The technology, while promising, lacks sufficient evidence for clinical use.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Y58haKj
via IFTTT

Read More

Budget for 'pharmacy of the world': What Sitharaman & Co can do to make medicines more affordable in India

Union Budget 2026: India's pharmaceutical landscape is on the brink of a transformative boom. To maintain this upward trajectory, the focus must shift towards fostering innovation and enhancing the efficiency of drug manufacturing. Strategic government funding is essential to bolster research initiatives, support production facilities, and strengthen healthcare frameworks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fv9FTCQ
via IFTTT

Read More